Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes

Aydin K., CANPOLAT U., Akin S., Dural M., Karakaya J., AYTEMİR K., ...More

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.16, no.10, pp.749-755, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 10
  • Publication Date: 2016
  • Doi Number: 10.5152/anatoljcardiol.2015.6629
  • Journal Name: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.749-755
  • Keywords: chemerin, diabetes, pulse wave velocity, atherosclerosis, carotid plaque, epicardial fat, EPICARDIAL ADIPOSE-TISSUE, ARTERIAL STIFFNESS, METABOLIC SYNDROME, CORONARY ATHEROSCLEROSIS, CARDIOVASCULAR MORTALITY, ENDOTHELIAL DYSFUNCTION, HYPERTENSIVE PATIENTS, CLINICAL-APPLICATIONS, INSULIN-RESISTANCE, AORTIC STIFFNESS
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Objective: Chemerin is a novel adipokine that is correlated with adipocyte differentiation, glucose metabolism, and inflammation. We aimed to investigate the relation between serum chemerin level and subclinical atherosclerosis markers as exemplified by brachial artery pulse wave velocity (baPWV), carotid intima-media thickness (CIMT), epicardial fat thickness (EFT), and carotid plaque presence in diabetes and prediabetes.